SOSV is a global venture capital firm that operates early stage startup development programs. SOSV’s programs are focused on two broad areas. The first is revolutionary deep technology that promises the betterment of humanity and the planet. The second is startups in emerging markets that are ripe for explosive growth. The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, series A, and later rounds while providing founders with ongoing support and community. As of January 2022, SOSV had more than 1,000 portfolio companies and $1.5 billion in assets under management, reflecting a 40% increase over 2020. SOSV’s programs include hard tech-oriented HAX and life-science driven IndieBio. Both offer deep technical and scientific expertise on-site as well as well-equipped lab and fabrication facilities and supply chain access. At Chinaccelerator and MOX, market-entry and growth experts help entrepreneurs in emerging markets around the world ramp quickly. SOSV’s latest program, dlab, fosters new players in the blockchain ecosystem. SOSV also operates the Genesis Consortium, a partnership between IndieBio and leading VCs and industry partners, including co-founding partner Mayfield, that provides an additional $250,000 in funding certain life sciences startups in the programs.